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Chapter 1 
 
 
General introduction  
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1. 1 Chemoprevention by natural components 
 
Currently available research shows that Mediterranean diet high in fiber, fruits, 
vegetables, and grain products, is associated with reduced risk of many cancers. This 
diet is not only rich in fruits and vegetables but the consumption of olive oil and olive 
products occupies a central position in the dietary tradition which guarantee a high 
intake of various vitamins and minerals and beneficial non-nutrient substances such as 
flavonoids (Visioli et al., 2000). Flavonoids, which are a family of polyphenolic 
compounds, comprise approximately 5000 compounds that are defined chemically as 
substances composed of a common phenylchromanone structure (C6-C3-C6), with one 
or more hydroxyl substitutes. Flavonoids are considered as one of the main bioactive 
constituents of plants. Many of them have shown to possess anticarcinogenic effects by 
interfering with the initiation, development and progression of tumors. This has led to 
an increased emphasis on cancer prevention strategies in which these dietary factors are 
utilized. There are two major diet based chemoprevention, namely cancer 
chemoprevention and dietary cancer prevention, with appreciable overlap between them. 
Cancer chemoprevention involves pharmacologic intervention with naturally occurring 
compounds to prevent, inhibit or reverse cancer. In contrast, plant-derived agents 
containing in diet are protective against a variety of diseases including cancer. The 
development of diet based chemopreventive approaches is very important in many 
incurable diseases such as cancer. Even though epidemiological studies provide us 
valuable suggestions, the molecular events on cellular and tissue levels present the solid 
confirmation of beneficial effects. Valuable research shows that plant based diets do not 
only reduce the incidence of cancer but in some cases inhibit its progression (Boggs et 
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al., 2010; Büchner et al., 2010; Kirsh et al.,2007).  
 
1. 2 Cancer and differentiation therapy 
 
Cancer is a major public health burden in Japan and in the world causing the 
diagnose of more than 11 million people and the death of about 8 million people every 
year worldwide, according to the World Health Organization (WHO). In Japan alone, a 
total of 364,872 people died of cancer, which accounts for 28.8% of all deaths and the 
main cause of all deaths in Japan, according to statistics compiled by the Ministry of 
Health, Labor and Welfare [http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei13/ 
dl/10_h6.pdf (accessed 12 January 2015)]. 
Cancer generally develops over long period of time with the initiation 
occurring by the change of some genes in normal cells by chemicals or other agents. 
The body generally repairs most such damage but if the cell reproduces itself before it is 
repaired, the daughter cell retains this genetic damage becoming the cancer cell. These 
cells continue to replicate themselves and grow into cell masses thus, promoting cancer. 
Nutritional factors might be the most important regulators in this step: some dietary 
elements may promote the growth of cancer but others such as plant derived compounds 
may reverse this promotion process (Galeone et al., 2006). Recent cancer cell research 
mainly focused on the death of malignant cells through apoptosis. However, inducing 
cancer cell apoptosis is usually achieved when cells cannot resist the high enough 
cytotoxic concentration of chemicals (Tsiftsoglou et al., 2003). A novel and potentially 
less toxic form of cancer therapy involves the application of agents that can induce 
cancer cell differentiation, which is the so-called differentiation therapy. This therapy is 
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treatment with agents inducing differentiation of neoplastic cells and is specific to only 
malignant cells instead of killing them through cytotoxicity. With respect to dietary 
factors the question is always aroused: can we achieve such a high concentration 
through the diet? There is another mild approach when we can induce cancer cells to 
differentiate and eliminate them from the body in natural way (Leszczyniecka et al., 
2001). According to a systematic assessment, tobacco smoking (19.5%) and virus 
infections (20.6%) are major causes of cancer in Japan. Low intake of fruits and 
vegetables accounts for a percentage of 1.3%, the fifth causes of cancer (Inoue, et al. 
2012).With regular consumption of plant-based diet phytochemicals may reverse cancer 
promotion process by inducing cancer cell differentiation (Visioli et al., 2000). 
 
1. 3 Functionality of Olive (Olea europaea L.) leaves 
 
Olive tree Olea europaea L. is an evergreen tree growing in several areas in the 
world including Mediterranean countries, Arabian Peninsula, India and Asia. However, 
it is famous to be the emblematic tree of Mediterranean basin where 11 million tons of 
olive oil is produced every year which corresponds to 98% of the global production (El 
and Karakaya, 2009). 
All parts of olive tree are an integral part of Mediterranean civilizations, habits, 
culture and economy. Since the old time, olive tree has been an imminent part of 
Mediterranean people life. The tree has been cultivated through civilizations for its fruit, 
oil, leaves, and wood. In fact, the fruit can be used either pickled or for olive oil 
extraction or for both purposes, depending on the tree variety. Olive fruits and olive oil 
are well studied and well documented for their alimentary uses and health benefits, 
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whereas other by-products like olive leaves are less studied.  
Olive leaves were used since old time for their medicinal and health benefits as 
tea or incenses. In fact, olive leaves are an interesting reservoir containing big amount 
of several secondary metabolites mainly polyphenols and flavonoids. In recent years, 
there has been high interest in the health benefit of olive-leaf tea (El and Karakaya, 
2009). Historically, olive leaves have been used as folk remedy for combating fevers 
and malaria (         -        et al., 2000). 
Accumulating evidences from our l bo   o y’s studies and others demonstrated 
that olive leaves extracts and their active compounds are endowed with several health 
benefit biological and pharmacological activities including anti-cancer (Bouallagui et al., 
2011; Han et al., 2009), anti-atherosclerosis, cardiovascular diseases and hypertension 
(Zrelli et al., 2011), anti-diabetic (Drira et al., 2011), anti-allergy (Yamada et al., 2008), 
anti-oxidant (Park et al., 2013), improving immune function (Park et al., 2013), and 
several other activities (El and Karakaya, 2009). In our previous study Abaza et al. 
(2007) reported that olive leaves extract induced differentiation in human leukemia 
cells. 
 
1. 4 Objective and composition of the thesis 
 
In this study the author focused on apigenin flavone which is abundantly 
present in common fruits and vegetables, such as parsley, onions as well as in olive 
products (oil, fruits and leaves). Our previous research showed that olive leaf extract 
induced granulocytic differentiation and one of the main constituent of the extract was 
apigenin (Abaza et al., 2007). Apigenin has shown remarkable promise as a potent 
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chemopreventive agent. It received much attention in recent years for its low toxicity in 
normal cells, whereas numerous studies with different human cancer cell lines have 
shown that apigenin inhibits cancer cell growth via the promotion of cell cycle arrest 
and apoptosis (Patel et al., 2007; Ruela-de-Sousa et al., 2010; Vargo et al., 2006). The 
natural glucosylated form of apigenin was used to elucidate its cancer cell 
differentiation capacity. Apigetrin (Fig. 1. 1), the natural form of apigenin, is more 
stable and has better solubility to compare with aglycone (Patel et al., 2007). 
Leukemia cell lines are widely used as in vitro model to investigate the effect 
of different chemicals on cancer cells differentiation. A characteristic feature of 
leukemia cell is a blockage of differentiation at a distinct stage of cellular maturation 
leading to the accumulation of immature cells. HL-60 cells (Fig. 1. 2), which were 
derived from the peripheral blood of a patient with acute promyelocytic leukemia (APL) 
and grown in culture as an established cell line, were used as the in vitro model for 
leukemia. 
The outline of this study is described as follows. Briefly in chapter 2, the author 
observes the differentiation inducing effect of apigetrin on HL-60 cells using animal cell 
culture assays. In chapter 3, it focuses on molecular mechanisms utilized proteomics 
approach to explain this phenomenon, which allows for the discovery of novel 
molecular mechanism. In chapter 4, the author    g   d 4 Tu isi   oli      i  i s’ l    s 
extracts grown in 5 sites in the northern part of Tunisia, for their total polyphenol, total 
flavonoid, and apigenin content and their anti-oxidant capacity using analytical 
micro-methods for possible valorization of apigenin as anti-cancer functional food. 
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Fig. 1. 1 Chemical structure of apigetrin 
 
 
 
 
 
 
 
 
 
 
Fig. 1. 2 HL-60 cells. The cells were observed by light microscopy (magnification × 
200)  
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Chapter 2 
 
 
Induction of differentiation of HL-60 
cells by apigetrin 
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2. 1 Introduction 
 
Apigenin is a flavonoid belonging to the flavone structural class and 
chemically known as 4', 5, 7,-trihydroxyflavone, with molecular formula C15H10O5 
whose molecular weight is MW 270.24. Apigenin is structurally forming yellow needles 
in pure form. Apigenin is abundantly present in common fruits, such as oranges and 
grapefruit; plant-derived beverages, such as tea; vegetables, such as parsley and onions; 
as well as in olive, wheat sprouts and some seasonings (Shukla et al., 2010). In natural 
sources, apigenin is present as apigetrin (Patel et al., 2007). Apigenin have received 
much attention in recent years for its low toxicity in normal cells compared to other 
structurally related flavonoids. Studies of several human cancer cell lines have shown 
that apigenin inhibits cancer cell growth via the promotion of cell cycle arrest and 
apoptosis (Patel et al., 2007; Ruela-de-Sousa et al., 2010; Vargo et al., 2006). However, 
few studies have reported on the cell differentiation effects induced by apigenin. 
HL-60 cells are human promyelocytic leukemia cell line that has a potential to 
differentiate into granulocytes or monocytes. Many compounds have been reported to 
induce differentiation of these cells; all-trans retinoic acid (ATRA) and 
dimethylsulfoxide (DMSO) are well known inducers for granulocytes while 
1α,25-dihydroxy vitamin D3 [1,25(OH)2D3] and 12-O-tetradecanoylphorbol 13-acetate 
(TPA) induce HL-60 cells to monocytes (Tsiftsoglou et al., 2003). In particular, ATRA 
which was initially a dietary factor have been used clinically for treatment of acute 
leukemia (Nowak et al., 2009). HL-60 cells committed to cellular maturation undergo 
an irreversible differentiation and loss of proliferation capacity (Tsiftsoglou et al., 
2003). 
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 In this chapter, the author tried to investigate to the differentiation inducing 
effect of apigetrin on HL-60 cells. 
 
2. 2 Materials and Methods 
 
2. 2. 1 Cell culture 
Human promyelocytic leukemia cell line HL-60 was obtained from the Riken 
Cell Bank (Tsukuba, Ibaraki, Japan) and grown in RPMI 1640 medium (Gibco 
Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal bovine 
serum (FBS, BioWest, Nuaillé, France) and 1% penicillin (5000 IU/ml)-streptomycin 
(5000 IU/ml) solution (ICN Biomedicals, Irvine, CA, USA) at 37 C in a 5% CO2 
atmosphere. Cells were subcultured every 3 days. 
 
2. 2. 2 Cell proliferation assay 
At approximately 80% confluence, HL-60 cells were harvested and seeded in 
96-well plates at 2.0 × 10
4
 cells per ml in medium. After overnight incubation, apigetrin 
(Sigma-Aldrich, St. Louis, MO, USA) in dilutions with medium was added to obtain 
final concentrations of 5, 10, 25 and 50 M. The cells were cultured for 24, 48 and 72 h, 
followed by the addition of 10 l of 5 mg/ml of 
3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT, Dojindo, 
Kumamoto, Japan). After 24 h of incubation, 100 l of 10% sodium dodecyl sulfate 
(SDS) was added and the cells were incubated for another 24 h to completely dissolve 
the formazan produced by the cells. The absorbance was spectrophotometrically 
determined at 570 nm using a multidetection microplate reader (Powerscan HT, 
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Dainippon Pharmaceutical, NJ, USA). Blanks were prepared at the same time to correct 
for the absorbance caused by sample color and by the inherent ability of the samples to 
reduce MTT in the absence of cells. 
 
2. 2. 3 Cell viability assay 
Cell viability was assessed using flow cytometry according to the 
m  uf   u   ’s i s  u  io s. HL-60 cells were seeded in 100 mm dish at 2.0 × 104 cells 
per ml in 10 ml of medium. After overnight incubation, cells were treated with 25 and 
50 M of apigetrin for 24, 48 and 72 h. After treatment, cells were suspended in Guava 
ViaCount reagent (Guava technologies, CA, USA), and incubated for 30 min in 
darkness at room temperature. The cell number and viability were measured by Guava 
PCA flow cytometry (Guava technologies, CA, USA). 
 
2. 2. 4 Cell cycle analysis 
To determine cell cycle phase distribution, flow cytometric analysis of cellular 
DNA content was performed. HL-60 cells were seeded in 100 mm dish at 2.0 × 10
4
 cells 
per ml in 10 ml of medium. After overnight incubation, cells were treated with 25 M 
of apigetrin for 24 and 48 h. After treatment, cells were collected, washed with 
phosphate buffered saline (PBS) twice and fixed in 70% of ice cold ethanol at 4 C for 
more than 12 h. The fixed cells were centrifuged at 500 × g for 5 min, the supernatant 
was removed, and the pellets were washed with PBS twice. The cells were suspended in 
Cell cycle reagent (Guava technologies, CA, USA), incubated for 30 min in darkness at 
room temperature, and measured by a Guava PCA flow cytometry (Guava technologies, 
CA, USA). 
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2. 2. 5 Cell morphology 
The cells were examined by light microscopy (Leica Microsystems, Wetzlar, 
Germany) to observe cell morphology. HL-60 cells were seeded in 100 mm dish at a 
density of 2.0 × 10
4
 cells per ml. After overnight incubation, cells were treated with 25 
M of apigetrin for 24, 48 and 72 h and the pictures were taken accordingly.  
 
2. 2. 6 Nuclear Staining 
The cells were examined by Giemza staining to observe the morphology of 
nucleus for distinguishing the degree of differentiation in blood immature cells. HL-60 
cells were seeded at a density of 2.0 × 10
4
 cells per ml. After overnight incubation, cells 
were treated with 25 M of apigetrin for 48 h. After treatment, culture medium was 
removed and cells were fixed in methanol 37 C for 3 min. The fixed cells were washed 
with MilliQ twice and stained with Giemza Stain Solution (Wako, Osaka, Japan). The 
cells were incubated for 30 min at 37 C in darkness. The cells were washed with PBS 
over 5 times, and air dry for observation under light microscopy (Leica Microsystems, 
Wetzlar, Germany). 
 
2. 2. 7 Cell differentiation assay 
HL-60 cell differentiation was determined by the expression of cell surface 
markers CD11b and CD14 measured by flow cytometry. 2.0 × 10
4
 cells per ml in 10 ml 
of medium were seeded in 100 mm dish. After overnight incubation, cells were treated 
with 25 M of apigetrin or 25 M of oleuropein for 48 h. 100 nM ATRA 
(Sigma-Aldrich, St. Louis, MO, USA) and 100 nM 1,25(OH)2D3 (Sigma-Aldrich, St. 
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Louis, MO, USA) treated cells were used as positive controls. After washing with cold 
PBS twice, 1.0 × 10
5
 cells were labeled with R-phycoerythrin-cyanine 5 (PC5) 
conjugated anti-CD11b antibody and phycoerythrin (PE) conjugated anti-CD14 
antibody (Beckman Coulter, CA, USA) for 30 min on ice in darkness. The cells were 
washed with cold PBS twice, and finally resuspended in 500 l of PBS for 
measurement. 
 
2. 2. 8 Functional activity assay 
To evaluate the functionality of differentiated HL-60 cells, Nitro blue 
tetrazolium chloride (NBT) reduction assay was performed. HL-60 cells were seeded 
into 100 mm dish at a density of 2.0×10
4
 cells per ml. After overnight incubation, cells 
w          d wi h 25 μM of apigetrin followed by incubation for 48 and 72 h. 100 nM 
ATRA (Sigma-Aldrich, St. Louis, MO, USA) treated cells were used as positive 
controls. After washing with growth medium, 1.0 × 10
6
 cells were incubated with 1 ml 
of 10% NBT in growth medium containing 10 ng/ml of Phorbol 12-myristate 13-acetate 
(PMA; Sigma-Aldrich, St. Louis, MO, USA) for 30 min at 37 C in darkness. The cells 
were washed with PBS twice, and finally resuspended in 1 ml of PBS and seeded into 
96-well plates for measurement. 10% SDS was added and the cells were incubated for 
another 24 h to completely dissolve the formazan produced by the cells. The absorbance 
was spectrophotometrically determined at 570 nm using a multidetection microplate 
reader (Powerscan HT, Dainippon Pharmaceutical, NJ, USA).  
 
2. 2. 9 Statistical analyses 
Results are expressed as mean  S.D. of triplicate experiments. Statistical 
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   lysis w s p  fo m d usi g S ud   ’s  -test. The p<0.05 was considered statistically 
significant. 
 
2. 3 Results 
 
2. 3. 1 Apigetrin inhibits cell proliferation of HL-60 cells 
First, in order to elucidate whether apigetrin has biochemical effects in a 
physiologically relevant dose, the cell proliferation with apigetrin was investigated 
using a MTT assay. MTT is reduced to formazan by mitochondrial enzyme in living 
cells. The reduction of MTT can depend on the living cells. HL-60 cells were treated 
with different doses from 0 to 50 M of apigetrin up to 72 h. In this experimental 
condition, apigetrin inhibited HL-60 cell proliferation in a time- and dose-dependant 
manner (Fig. 2. 1). After 48 h treatment with 25 M of apigetrin, the cell proliferation 
was inhibited to 35% compared with the control. 
  
-15- 
 
 
 
 
 
 
Fig. 2. 1 Effect of apigetrin on the proliferation of HL-60 cells.  
The cells were treated with various concentrations (5-50 M) of apigetrin for 24, 48 and 
72 h. The cell proliferaion was measured by MTT assay. CTR represents control cells 
treated with 1.0% ethanol in medium at the final concentration. Data are presented as a 
percentage of the control, and as the mean  S.D. of three independent experiments. 
*p<0.05 significantly different from the control. 
  
0
20
40
60
80
100
120
CTR 5 10 25 50
Concentration (µM)
C
el
l 
p
ro
li
fe
ra
ti
o
n
 (
%
 o
f 
C
T
R
)
24 h
48 h
72 h
 
*
*
*
*
* *
*
*
*
*
*
(A)(B) 
-16- 
 
2. 3. 2 Apigetrin induces growth inhibition of HL-60 cells 
Since MTT assay is based on mitochondrial activity of cells, the author cannot 
conclude whether the anti-proliferative effect was derived from apoptosis or growth 
inhibition only. To precisely define the cell growth inhibition effect by apigetrin, the 
author performed more specific cytotoxicity assay by flow cytometric analysis. This 
assay is based on a proprietary mixture of two DNA-binding dyes. The first, a 
membrane-permeant dye, stains all nucleated cells, helping to eliminate cellular debris. 
The second, a membrane-impermeant dye, stains only damaged cells and thus indicates 
compromised cell health in cells that it stains. HL-60 cells treated with apigetrin 
exhibited slow cell growth compared to control cells in a dose-dependent manner (Fig. 
2. 2A); at concentration of 25 M, the cell number had little increase. The viability of 
both control and treated cells at 5 M was nearly 97% during all incubation periods 
(24-72 h), while at 25 M treatment it was slightly decreased time-dependently (Fig. 2. 
2B). Nevertheless, the cell viability was over 90% throughout the experimental 
conditions, suggesting apigetrin did not cause apoptosis in HL-60 cells at selected 
concentrations (Fig 2. 2B, C). The results of cell number correlates well with the results 
of MTT assay (Fig. 2. 1). 
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Fig. 2. 2 Effect of apigetrin on the cell number and viability of HL-60 cells. The cells 
were treated with 5 and 25 M of apigetrin for 24, 48 and 72 h. The time-dependant 
effect of apigetrin on cell number (A) and viability (B) were measured by flow 
cytometry. (C) The dose-dependant effect of apigetrin (5, 25 M) on cell number and 
viability after 48 h incubation. CTR represents control cells treated with 0.5% ethanol in 
medium. Data are presented as the mean  S.D. of three independent experiments. 
*p<0.05 significantly different from the control. 
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2. 3. 3 Apigetrin modulates cell cycle progression in HL-60 cells 
As apigetrin induced significant growth inhibition of HL-60 cells, the author further 
analyzed its effect on the cell cycle distribution by measuring DNA content after 
staining with Propidium iodide (PI). Cells treated with apigetrin, showed accumulation 
of the cells in G2/M phase compared with the control (Fig. 2. 3A, B). The number of 
cells in G2/M phase with apigetrin treatment was increased to 37.8% and 56.7% after 24 
and 48 h of treatment respectively, while it was 30.7% and 29.7% in control cells 
respectively (Fig. 2. 3C, D). The accumulation of cells in G2/M phase was 
time-dependent. This result suggests that the growth inhibition driven by apigetrin was 
due to a block of cell cycle at G2/M phase. 
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Fig. 2. 3 Effect of apigetrin on the cell cycle distribution of HL-60 cells. The cell cycle 
distribution according to their DNA content revealed by propidium iodide-derived 
fluorescence was determined by flow cytometry. An example of the obtained flow 
cytometric profiles is shown as (A) treated for 24 h and (B) treated for 48 h. CTR 
represents control cells treated with 0.5% ethanol in medium and ApiG represents 
apigetrin-treated cells. The left peak indicates that the cells in G0/G1 phase while the 
right peak indicates the cells in G2/M phase, and the region between two peaks defines 
the cells at S phase. The cell cycle distribution of HL-60 cells treated with 25 M of 
apigetrin for 24 h and 48 h are shown in (C) and (D) respectively. Data are presented as 
the mean  S.D. of three independent experiments. *p<0.05 significantly different from 
the control. 
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2. 3. 4 Apigetrin induced the morphological changes in HL-60 cells 
The morphological changes observed in apigetrin-treated HL-60 cells were 
compared to control cells (Fig. 2. 4A). The control cells had the same morphology with 
round shape and smooth cell surface throughout treatment times (24-72 h), while at 24 h 
of treatment, treated cells became bigger with rough surface and were attached weakly 
to the bottom of the dish. To verify that the morphological changes of appearance could 
cause the intercellular changes, the cells stained with Giemsa solution to observe the 
morphology of nucleus. As shown in Fig. 2. 4B, the nucleus of almost all cells in 
control occupied the cells. Treated cells increased the number of cells with lobed 
nucleus compared to control cells.  
 
2. 3. 5 Apigetrin induced granulocytic differentiation in HL-60 cells 
In order to determine whether growth inhibition via cell cycle arrest by 
apigetrin is associated with differentiation, the expression of cell surface makers in 
HL-60 cells was detected by flow cytometry. CD11b and CD14 are both expressed in 
monocytes while the expression of CD11b only indicates granulocytic differentiation of 
the cells. As shown in Fig. 2. 5A,  h   o   ol   lls did ’   xp  ss bo h m  k  s of 
CD11b and CD14 antigens. ATRA-treated cells which is the positive control of 
granulocytic differentiation showed increase in the number of CD11b-positive cells only, 
while 1,25(OH)2D3-treated cells used for the positive control of monocytic 
differentiation showed increase in the percentage of both CD11b- and CD14-positive 
cells. After treatment with apigetrin, HL-60 cells expressed only CD11b marker similar 
with ATRA treatment and the population of CD11b positive cells was 39.1% while the 
control was 2.9% (Fig. 2. 5B). On the other hand, oleuropein, which is also abundantly 
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present in olive leaves, didn’t show differentiation effect in HL-60 cells. These results 
indicate that apigetrin induced differentiation of HL-60 cells to granulocytes, and the 
active compound in olive leaves for leukemia differentiation . 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2. 4 Effect of apigetrin on the morphology of HL-60 cells 
(A) The cells were treated for 24, 48 and 72 h with 25 M of apigetrin. The cells were 
observed by light microscopy (magnification × 400). Scale bar represents 10 m. The 
photos are representative of three independent experiments. (B) The cells were treated 
for 48 h with 25 M of apigetrin. The cells were stained with Giemsa solution and 
observed by light microscopy (magnification × 400). The photos are representative of 
two independent experiments. 
Control 24 h 
72 h 48 h 
Control Apigetrin (B) 
(A) 
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Fig. 2. 5 Effect of apigetrin on induction of differentiation of HL-60 cells. The cells 
were treated for 48 h with 0.5% ethanol (CTR), 25 M of apigetrin (ApiG), 25 M of 
oleuropein, 100 nM of ATRA, and 100 nM of 1,25-(OH)2D3. The differentiation analysis 
according to the expression of cell surface markers CD11b (granulocyte and monocyte 
specific) and CD14 (only monocyte specific) were determined by flow cytometry. 
Representative flow cytometric profiles are shown (A). The lines delimit the region of 
positive cells. The total percentage of positive cells (CD11b – two upper quadrants; 
CD14 – two right–side quadrants) is showed within each panel. (B) The differentiation 
data are expressed as a percentage of differentiated cells with the mean  S.D. of three 
independent experiments. *p<0.05 significantly different from the control. 
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2. 3. 6 Apigetrin increases NADPH oxidase activity in HL-60 cells 
Since the cell surface marker expression is the early stage of cellular 
maturation, the author cannot conclude whether the differentiation process was finished 
or stopped in the way of maturation. To further confirm the ability of differentiated 
HL-60 cells induced by apigetrin as the mature granulocytes, NBT reduction assay was 
performed. This method is based on the reduction activity of NADPH oxidase which is 
activated by PMA-stimulation and forms of superoxide anions to kill microbes. 
Apigetrin increased the NBT reductive activity in a time-dependent manner (Fig. 2. 6) 
similar with ATRA treatment. These results indicate that differentiated HL-60 cells by 
apigetrin have a bactericidal activity and may act as mature granulocytes. 
 
 
Fig. 2. 6 Effect of apigetrin on NADPH oxidasse activity of HL-60 cells. The cells were 
treated for 48 h with 0.5% ethanol (CTR), 25 M of apigetrin (ApiG), 100 nM of ATRA 
as positive control. The NADPH oxidase activity was measured by NBT reduction assay. 
CTR represents control cells treated with 0.5% ethanol in medium at the final 
concentration. Representative data of two independent experiments are shown as the 
mean  S.D. *p<0.05 significantly different from the control. 
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2. 4 Discussion 
 
Induction of differentiation is generally associated with a loss of proliferative 
capacity of cells. Several studies have been reported that the differentiation inducing 
agents exhibit anti-proliferative effect (Kim et al., 2009; Lee et al., 2007; Sánchez et al., 
2009; Tsolmon et al., 2009). The results indicate that apigetrin inhibited the cell 
proliferation in time- and dose-dependant manner (Fig. 2. 1). However, the cell viability 
was not decreased by treatment with apigetrin (Fig. 2. 2B), indicating apoptosis was not 
induced. Previous reports have presented anti-proliferative effect of apigenin via 
apoptosis in breast cancer, prostatic stromal, colon carcinoma as well as leukemia cells 
but the treatment concentrations were high enough for cytotoxic effect to induce 
apoptosis (Bektic et al., 2006; Choi et al., 2009; Vargo et al., 2006; Wang et al., 1999). 
Wang et al. (1999) demonstrated that 60 M apigenin induced apoptosis in HL-60 cells. 
In this experimental condition, the lower dose of apigetrin (25 M) contributes to the 
effect of anti-proliferation but not cytotoxicity on HL-60 cells. 
It was demonstrated that apigenin arrested the cell cycle at G2/M phase in 
various types of cancer cells (Choi et al., 2009; Ruela-de-Sousa et al., 2010; Wang et al., 
2000a).  Results in this chapter also show that apigetrin induced G2/M phase arrest on 
HL-60 cells which is the possible explanation of growth inhibition by apigetrin (Fig. 2. 
3). The cell cycle is mediated by many protein complexes such as CDKs, cyclins and 
CKIs through the cell cycle checkpoints. Cdc2 (CDK1) and cyclinB complex is the 
master switch for the G2/M phase transition (Kawabe, 2004). Previous studies showed 
that apigenin inhibits cdc2 kinase activity though exposure of a wide array of malignant 
cells (Shukla et al., 2010). Other potential regulatory effects of apigenin may increase 
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the expression of p21 which is the negative cell cycle regulatory molecule (Kawabe, 
2004). Apigenin has also been reported to up-regulate the expression of p21 in prostate, 
cervical and breast cancer cells (Choi et al., 2009; Ruela-de-Sousa et al., 2010). All 
these studies tried to explain the possible G2/M arrest mechanisms by apigenin 
treatment in different cell lines with connection to apoptosis. Normally, cells rely on the 
G1 checkpoint to protect against DNA damage leading to cell cycle arrest at G0/G1 
phase, however cancer cells have defective G1 checkpoint function (Kawabe, 2004). 
Thus, the G2 checkpoint could be a potential target for cancer therapy and the 
compounds modulating G2 checkpoint can be the attractive agents in cancer treatment. 
On the other hand, the cell cycle arrest in the common event observed during cell 
differentiation. 
The author studied the cell morphological changes during apigetrin treatment. In 
the first 24 h, the surface of treated cells lost their smoothness and their size became 
bigger compared to control cells; later these cells developed small protrusions and were 
attached weakly to the bottom of the dish (Fig. 2. 4A). Granulocytes have functional 
characteristics including cell adhesion, migration, chemotaxis and phagocytic activity. 
Besides HL-60 cells which were differentiated by DMSO also exhibited adhesion 
(Mansfield et al., 1993). These results demonstrate that apigetrin increased a number of 
cells with lobed nucleus (Fig. 2. 4B). According to the proceeds of differentiation of 
leukocytes, their nucleus is divided into 2-5 lobes connected by a fine nuclear strand or 
filament. The mature cells with lobed nucleus can be characterized as granulocytes. On 
the other hand, apigetrin reduced cell proliferation with no cytotoxic effect. Therefore 
the author hypothesized that apigetrin may have a potential of inducing differentiation 
of HL-60 cells accompanied with cell cycle arrest, and performed further studies with 
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differentiation marker analysis and NBT reduction assay. The results support my 
hypothesis and reveal that apigetrin has a potential to be not only anticancer agent by 
induction of cell cycle arrest but also inducer of cellular differentiation (Fig. 2. 4 and 2. 
5).  
Although the study did not take in consideration that two phenomena, 
differentiation induction and G2/M phase cell cycle arrest, occurred in same cells, 
isoflavon genistein inducing G2/M phase cell cycle arrest was reported to induce 
differentiation in HL-60 cells (Sánchez et al., 2009). It is believed that ATRA interacts 
with nuclear receptors to regulator gene transcription for differentiation and with cell 
membrane receptors to generate rapid nongenomic effects, including the activation of 
mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3-K), 
that signaling also mediate the cell cycle (Kandel et al., 2002). Sánchez et al. (2009) 
examined co-treatment of genistein and ATRA for detail evaluation of their mechanism, 
and they showed that MAPK and PI3-K inhibitors prevented both cell differentiation 
and G2/M phase cell cycle arrest. The mechanism by which genistein potentiates 
ATRA-induced HL-60 cell differentiation coincident with differentiation induction was 
suggested via MAPK and PI3-K signaling pathways. Moreover co-treatment with 
ATRA and nargenicin as the inhibitor of cell proliferation in different co-treatment time 
revealed pre-treatment of nargenicin was more efficient for their combination effect 
(Kim et al., 2009). Taken together, compounds which potentiate ATRA-induced HL-60 
cell differentiation could trigger terminal differentiation. More extensive experiments 
are needed to elucidate apigetrin effect on the relationship between cell cycle arrest and 
differentiation by co-treatment with ATRA. 
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Our previous study reported that apigetrin demonstrates the differentiation 
inducing effect on human chronic leukemia K562 cells toward erythrocytes (Tsolmon et 
al., 2011). A number of agents have been studied over years for cancer cell 
differentiation and some of them such as ATRA are used in clinical practice to treat 
leukemias. But none of them is ideal; they can be effective only in certain types of 
leukemia and their long term use possesses toxic effects. HL-60 and K562 cells are the 
models of acute and chronic myeloid leukemias respectively. The development of these 
leukemias is thought to be different in terms of origin and stages of development. The 
current studies suggest that apigetrin is capable of triggering terminal differentiation of 
different types of leukemia and has the good potential for the differentiation inducer. 
In this chapter, the author showed that apigetrin inhibited HL-60 cell growth, 
dose- and time-dependently, but did not cause apoptosis. The distribution of cells at 
different stages in the cell cycle indicated an accumulation of treated cells in G2/M 
phase. Moreover, apigetrin induced granulocytic differentiation of HL-60 cells. The cell 
cycle arrest is prerequisite for hematopoietic cell differentiation, generally at the G0/G1 
phase. Differentiation initiates within the G0/G1 phase and terminally differentiated cells 
are arrested at the G0/G1 phase cells b   us    lls do ’  di id    ymo     d  xi  f om 
the cell cycle. Although many studies attempt to clarify the correlation between cell 
cycle arrest and differentiation, the precise mechanisms are largely unidentified. The 
common view that the initiation of cell differentiation is most likely to occur at the 
G0/G1 phase was not followed in the case of apigetrin. Therefore it might be interesting 
to investigate the differentiation pathway with apigetrin treatment and explore novel 
players in the complex process of cellular signaling. With this purpose the author will 
perform proteomic analysis in the next chapter.   
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Chapter 3 
 
 
Molecular approach of differentiation 
induced by apigetrin 
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3. 1 Introduction 
 
The proteome of a cell provides information about the protein isoforms and 
ensemble of proteins expressed in that cell under specific physiological conditions and 
at a specific time (Vercauteren et al., 2007). Proteomic approaches provide several 
novel possibilities to address biological questions. The large-scale screening approach 
of proteomics enables protein expression studies that are impossible to perform using 
classical molecular biology techniques, in which the expression of only one or a few 
proteins is studied at a time for example like as western blot analysis. In fact, 
proteomics allow for the analysis of up to thousands of proteins simultaneously, in any 
tissue or organelle, under any given physiological condition. Moreover there is no 
limitation of proteins which have already been characterized by cellular functions or 
role in specific signal transduction pathways. 
 Cell cycle checkpoints are signal transduction pathways that ensure the timing, 
sequence, and fidelity of critical cell cycle events and assemble cellular responses to 
environmentally induced stress. Chk1 and Chk2, which relays the checkpoint activation 
signal and mediate cell cycle arrest, are structurally unrelated yet functionally 
overlapping serine/threonine kinases activated in response to various insults. Most 
of the stress signals from the sensor complexes are conducted via Chk1 and/or Chk2 to 
Cdc25C, which a main activator of the Cdc2/CyclinB complex. In briefly, activated 
Chk1 and/or Chk2 also phosphorylate Cdc25C, either leading to its inactivation 
(O’Co   ll et al., 2000). Taken together, the G2/M transition relies on the activation of 
Chk1 and/or Chk2 followed by unable activation of Cdc2/CyclinB complex. 
 In this chapter, the author tried to investigate molecular mechanisms of 
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granulocytic differentiation coupled with G2/M phase cell cycle arrest by apigetrin. 
Proteomic analysis allows for the discovery of novel molecular mechanisms and, 
opening novel research avenues. The relevant of Chk1 and Chk2 is as the candidate 
target for apigetrin with the object of cell cycle arrest. 
 
3. 2 Materials and Methods 
 
3. 2. 1 Cell culture 
Human promyelocytic leukemia cell line HL-60 was obtained from the Riken 
Cell Bank (Tsukuba, Ibaraki, Japan) and grown in RPMI 1640 medium (Gibco 
Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal bovine 
serum (FBS, BioWest, Nuaillé, France) and 1% penicillin (5000 IU/ml)-streptomycin 
(5000 IU/ml) solution (ICN Biomedicals, Irvine, CA, USA) at 37 C in a 5% CO2 
atmosphere. Cells were subcultured every 3 days. 
 
3. 2. 2 Two-dimensional gel electrophoresis and image analysis 
HL-60 cells were seeded in 100 mm dish at a density of 2.0 × 10
4
 cells per ml. 
After overnight incubation, cells were treated with or without 25 M of apigetrin 
followed by incubation for 48 h. The medium was then removed and the cells were 
washed twice with PBS before the total protein was extracted using lysis buffer [7 M 
Urea, 2 M Thiourea, 4% CHAPS, 40 mM dithiothreitol (DTT), 1 mM EDTA, 25 mM 
Spermine base]  o   i i g p o   s  i hibi o     o di g  o  h  m  uf   u   ’s 
instructions. Samples were stayed for 1 h at room temperature and centrifuged at 17000 
× g for 100 min at 15 C, and then supernatants were carefully collected. The protein 
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concentration was determined by 2D Quant Kit (GE Healthcare, Little Chalfont, UK). 
The protein samples (350 g) were rehydrated with rehydration buffer (7 M Urea, 2 M 
Thiourea, 2% CHAPS, 15 mM DTT) and isoelectrically focused in IPG Buffer (0.5%) 
using Immobiline IPG DryStrips (240 mm, pH 3–10, GE Healthcare, Little Chalfont, 
UK) for 12 h at 45 kVh on Ettan IPGphor system (GE Healthcare, Little Chalfont, UK). 
Focused strips were equilibrated and SDS–PAGE was performed using 12.5% 
polyacrylamide gels in Ettan DALT six Large Electrophoresis System (GE Healthcare, 
Little Chalfont, UK). Following electrophoresis, gels were fixed and stained with 0.1% 
Coomassie Brilliant Blue G-350 in 30% methanol and 10% acetic acid. Gel image 
analysis was performed using software ImageMaster 2D Platinum ver. 5.0 (GE 
Healthcare, Little Chalfont, UK). Intensity levels were normalized between gels as a 
proportion of the total protein intensity detected for the entire gel. Protein spots with 
normalized volume of over two fold differences were excised. 
 
3. 2. 3 In gel digestion 
Excised spots were destained with 25 mM ammonium bicarbonate for 30 min. 
The spot pieces were washed with 100% acetonitrile (ACN) and dried completely 
followed by reduction and alkylation with 10 mM DTT and 25 mM iodoacetamide 
respectively. After washing with ACN and drying in a speedVac (Genevac, Ipswich, 
UK), gels were kept at 4 C for 30 min in trypsin solution (10 g/ml modified 
sequence-grade trypsin, 50 mM ammonium bicarbonate), then 50 mM ammonium 
bicarbonate was added to prevent gel pieces from drying during the digestion at 37 C 
overnight. After digestion, the resulted peptides were extracted twice with 5% formic 
acid in 50% ACN. 
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3. 2. 4 Liquid chromatography-tandem mass spectrometry 
Liquid chromatography-tandem mass spectrometry (LC/MS/MS) analysis was 
performed for protein identification using 3200 QTRAP MS/MS system (Applied 
Biosystems, Waltham, MA, USA) coupled with Ultimate 3000 LC (Dionex, Sunnyvale, 
CA, USA). After sample injection by autosampler, the column was washed for 5 min 
with 98% mobile phase A (0.1% formic acid in water) at a flow rate of 0.3 L/min. 
Peptides were eluted from the column using a linear gradient of 2% mobile phase B 
(0.1% formic acid in ACN) to 40% mobile phase B in 10 min at a flow rate of 0.3 
L/min, then to 90% mobile phase B for an additional 5 min. The column effluent was 
directed into the electrospray source. The electrospray voltage was set at 2.3 kV. Full 
MS scan range was 400-1200 m/z, spectra were acquired automatically in Information 
Dependent Acquisition (IDA) analysis. Protein identification was performed using 
Mascot software (www.matrixscience.com) and searched against swiss prot database. 
Search criteria were defined as follows: enzyme as trypsin, taxonomy as Homo sapiens, 
missed cleavage of 1, fixed modifications as carbamidomethylation of cystein and 
variable modifications as oxidation of methionine. MASCOT protein score >34 was 
considered to be significantly different (p<0.05). 
 
3. 2. 5 Real Time-PCR (RT-PCR)  
HL-60 cells were seeded into 100 mm dish at a density of 2.0×10
4
 cells per ml. 
Af    o    igh  i  ub  io ,   lls w          d wi h 25 μM of apigetrin followed by 
incubation for 3, 6, and 12 h. The medium was then removed and the cells washed twice 
with PBS. Total RNA was isolated using the ISOGEN kit (Nippon Gene Co. Ltd., 
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Tokyo, J p  ) followi g  h  m  uf   u   ’s i s  u  io s. To  l RNA w s qu   ifi d   d 
their quality measured by Nanodrop 2000 (Thermo scientific, Waltham, MA, USA). 
Reverse transcription reactions were carried out with the Superscript III reverse 
transcriptase kit (Invitrogen, Carlsbad, CA, USA) using 1 g of total RNA. RT-PCR 
was performed using 100 ng of cDNA, Taqman Fast Universal PCR Master Mix, and 
the following Taqman Gene Expression Assays; 14-3-3 beta (Hs00793604_m1), 14-3-3 
epsilon (Hs00356749_g1), 14-3-3 gamma (Hs00705917_s1),  Glycosidase 2 subunit 
beta ( Hs00160457_m1), Histone-binding protein RBBP4 (Hs001568507_g1), and 
Actin-beta (Hs03023880_g1). The cDNA amplification reactions were run on the 7500 
fast RT-PCR system (Applied Biosystems, Waltham, MA, USA) and normalized to the 
endogenous control. 
 
3. 2. 6 Western blotting 
HL-60 cells were seeded into 100 mm dish at a density of 2.0×10
4
 cells per ml. 
Af    o    igh  i  ub  io ,   lls w          d wi h 25 μM of apigetrin followed by 
incubation for 6, 12, 24, and 48 h. The medium was then removed and the cells washed 
twice with PBS before the total protein was extracted using RIPA buffer (Sigma-Aldrich, 
St. Louis, MO, USA)  o   i i g p o   s  i hibi o     o di g  o  h  m  uf   u   ’s 
instructions. Samples were centrifuged at 100,000 rpm for 20 min at 4 C, and then 
supernatants were carefully collected. The protein concentration was determined by 2D 
Quant Kit (GE Healthcare, Little Chalfont, UK). P o  i  s mpl s (15 μg /well) were 
mixed with sample buffer [5 mM Tris-HCl pH 6.8, 10% (v/v) glycerol, 10% (v/v) 
β-mercaptoethanol, 2% SDS, 0.1% bromophenol blue] and then protein samples were 
electrophoresed on 10% SDS-polyacrylamide gel. Proteins were transferred to 
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nitrocellulose membrane, and blocked with block ace for 1 h and incubated with 
primary antibodies for 2 h at room temperature then washed three times in TBST (TBS
＋0.01% Tween-20). Appropriate conjugated secondary antibodies were used for 1.5 h 
in room temperature then washed three times in TBST. The specific protein bands were 
detected with ECL prime (GE Healthcare, Little Chalfont, UK). Antibodies against 
Chk1 and Chk2 were purchased from Abcam (Cambridge, UK), p-chk2 and p-Chk2 
were purchased from Cell Signaling Technology (Danvers, MA, USA) and actin were 
purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). 
 
3. 2. 7 Statistical analyses 
Results are expressed as mean  S.D. of triplicate experiments. Statistical analysis was 
p  fo m d usi g S ud   ’s  -test. The p<0.05 was considered statistically significant. 
 
3. 3 Results 
 
3. 3. 1 Identification of differential expression of proteins in HL-60 cells with or 
without apigetrin treatment 
To further characterize the mechanism by which apigetrin induced granulocytic 
differentiation of HL-60 cells, the protein expression changes in treated HL-60 cells 
compared to control cells were analyzed using proteomics. 330 spots were detected in 
each gel after CBB staining and more than 80% of protein spots were matched (Fig. 3. 
1A). From the gels, the author selected 10 spots, which were found to be differentially 
expressed and showed >2-fold change (Fig. 3. 1B). These spots were excised and 
digested with trypsin and the proteins were identified by LC/MS/MS. In Table. 3. 1, 
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identified protein names, their mascot score, pI/MW and value of fold change compared 
to control are listed. All identified proteins were up-regulated by apigetrin and 
associated with the process of differentiation. The up-regulation of proteins was 
confirmed by the expression of mRNAs of selected proteins by RT-PCR experiments 
(Fig. 3. 3). As the result, three proteins, 14-3-3 proteins (beta, epsilon and gamma) 
observed no significant changes at the mRNA level, while other 2 proteins demonstrated 
similar expression patterns to what the proteomic analysis showed. 
 
3. 3. 2 Apigetrin induces the phosphorylation of Chk1 and Chk2 
 To examine the involvement of checkpoint kinases in apigetrin -induced HL-60 
cell differentiation, Chk1 and Chk2 phosphorylation were investigated by western 
blotting with their phosphor-specific antibodies, which recognize activated Chk1 at 
Ser345 and activated Chk2 at Thr68, respectively. When HL-60 cells were treated with 
apigetrin for 24 and 48 h, the phosphorylation levels of Chk1 and Chk2 were increased 
(Fig. 3. 4). The expressions of Chk1 and Chk2 proteins were not affected by the 
treatment of apigetrin though treatment time. These data suggest that apigetrin activates 
both Chk1 and Chk2 proteins, which is relevant not only to cell cycle arrest but also 
granulocytic differentiation. 
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Fig. 3. 1 (A) An overview of representative 2D gel images obtained from control HL-60 
cells and treated HL-60 cells with apigetrin (ApiG) for 48 h. 2DE gels were stained with 
CBB. Proteins differentially expressed were marked by arrow. Data presented is 
representative of three independent experiments. (B) Specific regions of 2D gel image 
indicating protein spots with altered expression compared to control. Information on 
each numbered spot is summarized in Table. 3. 1 ApiG represents apigetrin-treated cells. 
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Fig. 3. 2 Total ion count chromatogram of peptides from excised protein gel spots 
detected by nano-HPLC (upper side). Example of MS/MS fragment of one product ion 
analyzed by Mascot software (middle side). Matched peptides showed in bold red 
(lower side). (A)Spot1. Glucosidase 2 subunit beta (LWEEQLAAAK). (B)Spot2. 
Plastin-2 (VYALPEDLVEVNPK). (C)Spot3. Coronin-1A (ADQCYEDVR). (D)Spot4. 
Histone-binding protein RBBP4 (TVALWDLR). (E)Spot5. Proliferating cell nuclear 
antigen (CAGNEDIITLR). (F)Spot6. Elongation factor 1-beta (SIQADGLVWGSSK). 
(G)Spot7. 14-3-3 protein epsilon (VAGMDVELTVEER). (H)Spot8. 14-3-3 protein 
beta/alpha (AVTEQGHELSNEER). (I)Spot9. 14-3-3protein gamma (VISSIEQK). 
(J)Spot10. Annexin A5 (SEIDLFNIR). 
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Table. 3. 1 List of proteins affected by apigetrin and identified by LC/MS/MS. 
Spot 
no. 
Protein name Score
a
 Theoretical
b
 Observed Fold 
change
c
 pI MW pI MW 
1 Glucosidase 2 subunit 
beta 
71 4.33 60.4 4.43 90.5 2.25 
2 Plastin-2 221 5.20 70.8 5.80 67.0 2.35 
3 Coronin-1A 83 6.25 51.7 7.63 58.0 2.25 
4 Histone-binding protein 
RBBP4 
45 4.74 47.9 4.97 53.0 2.12 
5 Proliferating cell 
nuclear antigen 
261 4.57 29.1 4.78 33.0 2.03 
6 Elongation factor 
1-beta 
67 4.50 24.9 4.60 29.5 2.22 
7 14-3-3 protein epsilon 122 4.63 29.3 4.77 28.5 2.29 
8 14-3-3 protein 
beta/alpha 
138 4.76 28.2 5.10 27.0 2.77 
9 14-3-3 protein gamma 79 4.80 28.5 5.07 26.5 4.09 
10 Annexin A5 132 4.94 36.0 5.63 30.5 2.74 
a
 Mascot score of >34 was considered as significant (p<0.05). 
b
 Theoretical pI and MW were derived from the amino acid sequence in swiss prot. 
c
 Fold-changes of spot volume (Apigetrin vs. control). 
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Fig. 3. 3 Effect of apigetrin on the expression of Histone-binding protein RBBP4 (A), 
Glucosidase 2 subunit beta (B), 14-3-3 beta (C), 14-3-3 epsilon (D) and 14-3-3 gamma 
(E) mRNAs of HL-60 cells. The cells were treated with 25 M of apigetrin for 3, 6 and 
12 h. CTR represents control cells treated with 0.5% ethanol in medium. RT-PCR was 
performed using the following Taqman Gene Expression Assays; Histone-binding 
protein RBBP4 (Hs01568507_g1) and Glucosidase 2 subunit beta (Hs00160457_m1) on 
the 7500 fast RT-PCR system (Applied Biosystems) and normalized to the endogenous 
control -actin (Hs03023880_g1). Representative data of two independent experiments 
are shown as the mean  S.D. *p<0.05 significantly different from the control. 
 
 
0.5 
0.6 
0.7 
0.8 
0.9 
1 
1.1 
1.2 
1.3 
1.4 
1.5 
CTR 3 h 6 h 12 h 
R
e
la
ti
v
e
 e
x
p
re
s
si
o
n
 
Treatment time 
0.5 
0.6 
0.7 
0.8 
0.9 
1 
1.1 
1.2 
1.3 
1.4 
1.5 
CTR 3 h 6 h 12 h 
R
e
la
ti
v
e
 e
x
p
re
s
si
o
n
 
Treatment time 
 
(D) 
(E) 
-54- 
 
 
 
 
Fig. 3. 4 Effect of apigetrin on phosphorylation status of checkpoint kinases in HL-60 
cells. The cells were treated with 25 M of apigetrin for 6, 12, 24 and 48 h. CTR 
represents control cells treated with 0.5% ethanol in medium. The cells were lysed and 
immunoblotted with antibodies against Chk1, phospho-Chk1, Chk2, phospho-Chk2 and 
actin. Representative data of two independent experiments are shown. 
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3. 4 Discussion 
 
Proteomics is one of the most valuable tools to analyze the poorly unknown 
mechanisms. Traditional techniques of molecular biology were usually highly focused, 
targeting one or few molecules at a time, whereas proteomics provide possible overview 
of large-scale protein expression changes. The author identified 10 proteins consistently 
modulated in response to apigetrin treatment by proteomic approach (Table. 3. 1). 
Apigenin has been reported to inhibit the proteasome activity in human leukemia cells 
and it gives the possible explanation the up-regulation of all selected proteins (Chen et 
al., 2005). 
First, the expression of glucosidase 2 subunit beta protein was increased in 
apigetrin treated-cells. This protein is regulatory subunit of -glucosidases which 
hydrolyses flavonoid glycosides. In human small intestine two of the -glucosidase, one 
of which bound in membrane and the other distributed in cytosol, hydrolyze flavonoid 
glucosides in distinct pathway (Németh et al., 2003), for instance quercetin glucoside 
has been reported to be absorbed via sugar transporters and to be hydrolysed by 
-glucosidase (Heim et al., 2002). These previous reports provide a possible 
explanation for better bioavailability of glucosides. Expression of glucosidase 2 subunit 
beta suggests that apigetrin might be hydrolyzed by -glucosidase and released 
aglycone could affect HL-60 cells. 
When apigenin is taken orally, it reaches the gut and is extensively metabolized 
and converted by phase I and phase II enzymes. In vitro study has demonstrated that 
apigenin was converted to the three mono-hydroxylated derivatives via phase I 
metabolism (Gradolatto et al., 2004). Apigenin and luteolin which are the major phase 
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metabolite of these derivatives, were conjugated to three mono-glucuronated and one 
mono-sulfated compounds, and four mono-glucuronated, two sulfated and one 
methylated compounds respectively via phase II metabolism in vitro (Gradolatto et al., 
2004). These observations suggest that the bioavailability of apigenin is limited, but 
Gradolatto et al. (2005) have shown that a single oral administration of radio-labeled 
apigenin in rats resulted in 24.8% in the rest of the body within 10 days and also its 
radioactivity appeared in blood after 24 h but eliminated slowly. These results suggest 
slow metabolism of apigenin and give rise to the possibility of an accumulation of 
apigenin in the body and tissue for its effective chemopreventive properties. 
Furthermore apigenin was shown to have no mutagenic activity and effects to normal 
cells such as liver and prostate cells (Chiang et al., 2006; Gupta et al., 2001); normal 
human peripheral blood lymphocytes were not affected by apigenin even at high 
concentrations: the viability of cells was over 80% with apigenin treatment at 200 M 
(Ruela-de-Sousa et al., 2010). These reports indicate that apigenin has low intrinsic 
toxicity even though flavonoids are present in systemic circulation at low micro-molar 
concentration and differential effects in normal versus cancer cells. However, further 
studies about the metabolism of apigenin and the usage of administration are needed to 
develop apigetrin as a food-based anti-leukemia compound. 
Next identified proteins were 3 isoforms of 14-3-3 proteins. 14-3-3 proteins are 
a family of highly conserved molecules that play important roles in a wide range of 
cellular processes within all eukaryotic cells and seven isoforms are identified in 
mammals (Tzivion et al., 2002). 14-3-3 and 14-3-3 were reported to make a complex 
with tyrosine phosphatase cdc25C and inhibit its entry into the nucleus (Dalal et al., 
2004). In the cell cycle progression, the cytoplasmic localization of cdc25C does not 
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activate the cyclinB/cdc2 complex and induce G2/M     s  (O’Co   ll et al., 2000). 
14-3-3 expression is also related to G2/M cell cycle arrest by indirect inhibition of cell 
division control protein cdc2 activity (Wang et al., 2000b). Overall observation of this 
study supports the involvement of 14-3-3 proteins in G2/M arrest particularly with 
apigetrin treatment of cancer cells. 
Other regulatory proteins up-regulated during the HL-60 cells differentiation 
were Proliferation cell nuclear antigen (PCNA) and Elongation factor 1- (EF-1). 
Although all of the PCNA functions described to date reflect its crucial role in DNA 
synthesis and repair, recent studies of Witko-Sarsat et al., demonstrated its specific 
function in neutrophils exclusively (Naryzhny, 2008; Witko-Sarsat et al., 2010). Unlike 
macrophages and other cells which showed low-level expression of PCNA during 
off-proliferation, differentiated neutrophils do not proliferate but highly expressed 
PCNA protein, which was shown to be associated with procaspases protecting 
neutrophils from apoptosis. The observations with less apoptotic feature but cell 
differentiation with apigetrin in the chapter 2 supports this evidence. Interestingly, the 
expression of PCNA protein increases steadily though the whole cell cycle term and 
remains high at G2/M phase (Zeng et al., 1994), further interacting with cdc25C at G2/M 
transition (Kawabe et al., 2002) and with EF-1 (Naryzhny, 2008). EF-1 exchanges 
GDP for GTP to regenerate active EF-1. This active EF-1 is then able to perform 
another round of elongation of polypeptide chain (Le Sourd et al., 2006). Increase in 
size of differentiated cells (Fig. 1B) may implicate the active protein synthesis, which 
could lead to the increase of EF-1 in protein level. 
Histone acetylation is important chromatin modification reaction controlling 
gene transcription. In this process, histone deacetylase 1 (HDAC1) was reported to form 
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a complex with PU.1 to act as transcriptional repression (Nicolas et al., 2001; Suzuki et 
al., 2003) and PU.1 is known to be suppressed in human leukemic cells but in the 
process of granulocytic differentiation its expression is increased (Mueller et al., 2006). 
The observed up-regulation of plastin-2, Annexin A5 and Coronin-1A with apigetrin 
treatment confirms granulocytic differentiation in terms of granulocytes characteristic 
features. Plastin-2 and Annexin A5 are reported to be the components of NADPH 
oxidase system (Babior, 1999; El Btaouri et al., 1996; Karlsson et al., 2005; Kim et al., 
1994; Mira et al., 1997; Munshi et al., 2002; Oshizawa et al., 2003) which is the basis 
of NBT reduction assay to identify the differentiated granulocytes and also I reported 
that apigetrin increased the NBT reductive activity in chapter 2. Coronin-1A is a 
member of actin-associated proteins that have been implicated in a variety of cellular 
processes dependant on actin rearrangements. In primary human neutrophils, the 
expression of coronins is required for actin-dependant changes in cell morphology that 
lead to migration and chemotaxis (Yan et al., 2007). Morphological observations of the 
differentiated cells with apigetrin also showed the protrusions and pseudopod 
developments in HL-60 cells with weak attachment to the dish. These 3 proteins support 
these results of apigetrin induced granulocytic differentiation in HL-60 cells. 
The RT-PCR results revealed that of the 5 differentially expressed proteins 
identified by proteomic analysis, two showed similar changes at the mRNA and protein 
levels. However, there were no clear changes at the mRNA levels for 14-3-3 proteins 
after apigetrin treatment, although their expression increased at the protein level. A 
study of the myeloid differentiation in MPRO murine cells by Lian et al. (2002) in 
which both mRNA and protein have been compared in the same sample have also 
shown that there is not a good correlation between mRNA and protein levels. The 
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discrepancy between mRNA and protein level may indicate the importance of 
post-transcriptional and post-translational processes during cell differentiation.  
One of proteins which were identified by proteomic analysis is the signal 
transduction molecules of 14-3-3 proteins. 14-3-3 proteins are phosphorylated to bind 
protein ligands. Hence the author focused in Chk1 and Chk2 protein, which is the 
up-stream protein for 14-3-3 proteins and regulated the phosphorylation of 14-3-3 
proteins to transduce cell signaling (Okada et al., 2010). Chk1 and Chk2 are 
functionally related kinases that phosphorylate overlapping pools of cellular substrates, 
although these proteins have distinct regulatory domains. To directly investigate the role 
of Chk1 and Chk2 in apigetrin-induced the differentiation of HL-60 cell, western blot 
analysis was performed. Results support my hypothesis the activation of Chk1 and 
Chk2 is involved the effect of apigetrin. Chk1 has been reported to be mainly 
responsible for phosphorylation of substrates while Chk2 plying a supplementary role, 
and it gives the possible explanation the early activation of Chk1 compared with Chk2 
(Okada et al., 2010). Generally Chk1 and Chk2 play a central role in implementing 
many aspects of cell cycle check point response; cell cycle arrest or induction of 
apoptosis. Recent study of Carrassa et al., demonstrated a possible role of Chk1 in 
hematopoietic stem cell differentiation isolated from umbilical cord blood (Carrassa et 
al., 2010). Moreover the activation of both Chk1 and Chk2 is critical for Ara-C-induced 
erythroid differentiation, which is famous inducer of erythroid differentiation (Takagaki 
et al., 2005). Taken together, Chk1 and Chk2 are at a key cross-road where many 
biological processes meet; cell cycle progression, apoptosis, DNA repair and 
differentiation. Results of this study suggest that apigetrin- induced granulocytic 
differentiation of HL-60 cells is mediated by both Chk1 and Chk2 pathways. However it 
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remains to be seen which effect is dominant in the activation of Chk1 and Chk2. 
It has been unknown what the molecular target of apigetrin is, however recent 
study has revealed apigenin binding target proteins by Phage Display sequencing for 
comprehensive identification (Arango et al. 2014). Apigenin (and likely, other flavones) 
directly interacts with heterogeneous nuclear ribonucleoprotein A2 (hnRNPA2), 
inhibiting its dimerization/activation and altering the alternative splicing patterns of 
hnRNPA2 substrates. Choi et.al. reported (2013) hnRNP A2/B1 is essential for human 
ES Cells self-renewal and pluripotency. Moreover hnRNP A2/B1 knockdown inhibited 
hESC proliferation by inducing phosphorylation of Chk1 though 
Akt/phosphatidylinositol 3-kinase (PI3K) pathway. This pathway has been reported to 
phosphorylate Chk1 (King et al., 2004). hnRNP A2 expressed even in HL-60 cells 
(Gallo et al., 2014). To the best of knowledge, apigetrin is proposed that a possibility of 
molecular target is hnRNPA2 in HL-60 cells. Further studies are required in order to 
clarify downstream events in Chk1 and Chk2-mediated signaling pathways during 
differentiation. 
In this chapter, the author showed that ten proteins that might play essential 
role in granulocytic differentiation which is previously-unreported as proteins related to 
differentiation, and a possible role for Chk1 and Chk2 in the granulocytic differentiation 
on HL-60 cells. On the basis of these results and reports, the author proposes a possible 
mechanism for apigetrin- induced granulocytic differentiation of HL-60 cells (Fig. 3. 5). 
Apigenin, which is hydrolyzed by glucosidase from apigetrin, inactivates hnRNPA2, 
and each kinases phosphorylate Chk1 and Chk2, which might lead to signal 
transduction toward G2/M cell cycle arrest through 14-3-3 proteins and granulocytic 
differentiation though transcriptional repression by PU.1. 
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Fig. 3. 5 Proposed pathways of apigetrin- induced granulocytic differentiation in HL-60 
cells. 
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Chapter 4 
 
 
Apigenin quantification and phenolic 
profiling of olive (Olea europaea L.) 
leaves from Tunisia 
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4. 1 Introduction 
 
Olive tree Olea europaea L. is an evergreen tree growing in several areas in the 
world, and is famous to be the emblematic tree of Mediterranean basin. Olive fruits and 
olive oil are well studied and well documented for their alimentary uses and health 
benefits, whereas other by-products like olive leaves are less studied.  
Olive leaves were used since old time for their medicinal and health benefits as 
tea or incenses. In fact, olive leaves are an interesting reservoir containing big amount 
of several secondary metabolites mainly polyphenols and flavonoids. Accumulating 
evidences demonstrated that olive leaves extracts and their active compounds are 
endowed with several health benefit biological and pharmacological activities. In 
previous chapter, the author demonstrated apigetrin is the most bio-active compound 
against leukemia using HL-60 cells. Even though these studies provide us valuable 
suggestions the functionalities of apigenin for human health, however the chemical 
contents of apigenin in olive leaves is not fully evaluated. On the other hand, oleuropein, 
which was also thought as the bioactive components in olive leaves with their high 
anti-oxidant activity, has been reported their content in olive by Bouaziz et al. (2004) 
and Salah et al. (2012). The chemical composition of olive products differs depending 
on several conditions such as the variety, the growing area, the season and the plant part 
(Luján et al., 2009). 
Tunisia is an important olive oil producing and exporting country, where olive 
tree plantation is estimated to around 70 million trees, covering almost 30% of Tunisian 
arable land (1.7 Million Hectares). It is occupying the fourth position as olive oil 
exporter in the world. In Tunisia, olive sector is representing 59.8 % of agro-products 
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exportation, and is offering 34 million working day/year, that is corresponding to 20% 
of employment capacity in Tunisia (Kashiwagi et al., 2012). Despite its small area, there 
is 70 million olive trees and there are dozens of identified cultivars in the country with 
great environmental diversity due to its north-south extent. 
In this chapter, the author conducted the current research in order to quantify 
the amounts of apigenin and apigetrin from 4 different varieties of Tunisian olive tree 
grown in the northern part in Tunisia, to determine total polyphenol and flavonoids 
content and the antioxidant capacity of olive leave extracts. 
   
4. 2 Materials and Methods 
 
4. 2. 1 Preparation of olive leaves’extracts  
Olive leaves were collected from Tunisia at 16 or 17 November 2011. The 
olive leaves used for this study were collected from 4 varieties; Chetoui, Meski, 
Chemlali and Sahli, grown in 5 various regions of North part in Tunisia (Table. 4. 1, Fig. 
4. 1). Olive leaves were dried at room temperature and protected from the light. and 
ground to powder with an electrical blender. Then dried powder sample (1 g) was 
extracted with 10 ml 70% ethanol (EtOH) (w/v) at room temperature in darkness for 2 
weeks. The obtained solution was filter-sterilized by 0.22 m filter (Millipore) then 
stored -80 C until use. Dry weight (DW) in each sample was evaluated after solvent 
evaporation under vacuum at 37°C using Speed Vac (Genevac, Ipswich, UK). 
 
4. 2. 2 High Performance Liquid chromatography (HPLC) 
HPLC analysis was performed using Ultimate 3000 LC (Dionex, Sunnyvale, 
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CA, USA) and Acclaim C18 column (150×1.0 mm i.d.) thermostated at 40 C. The flow 
rate was 35 L/min and the detection was performed at 280 nm. A linear gradient was 
run from 80% of solvent A (10 mM phosphoric acid in water) and 20% of solvent B 
(Acetonitrile). Then Solvent B was increased to 55% in 10 min, then up to 85% within 5 
min, and kept isocratic for 5 min. The HPLC-grade standards apigetrin was obtained 
from Sigma-Aldrich (St Louis, MO, USA), and aglycone apigenin was obtained from 
Merck (Whitehouse Station, NJ, USA). Apigenin and apigetrin in different extracts 
were identified by comparison of their retention times with the standards. 
 
4. 2. 3 Total phenolic content  
Total phenolic content in olive leaves was determined using a Folin–Ciocalteu 
reagent method (Singleton and Rossi, 1965) with some modification for micro-method. 
To 70 l of diluted extract or a standard solution of gallic acid (Sigma-Aldrich, St. 
Louis, MO, USA), 70 l Folin–Ciocalteu reagent (1:4 v/v in ddH2O) were added in 96 
well plate and allowed to stand for 3 min at room temperature. Then 70 l Na2CO3 
(wako, Japan, 10% w/v in ddH2O) were added. The plate was incubated for 60 min at 
room temperature. Then, the absorbance was recorded at 760 nm using a multidetection 
microplate reader (Powerscan HT, Dainippon Pharmaceutical, NJ, USA). The results 
were expressed as gallic acid equivalents (GAE) in mg/g of olive leaves extract dry 
weight (mg GAE g
–1
). All extracts were analyzed in triplicate. 
 
4. 2. 4 Total flavonoid content 
Total flavonoid content was determined using a colorimetric assay (Kim et al., 
2003) with some modifications for micro-method. To 150 l of diluted extract or a 
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standard solution of quercetin (Sigma-Aldrich, St. Louis, MO, USA) in EtOH, 7.5 l 
NaNO2 (wako, Japan, 5% w/v in ddH2O) were added the mixture in 96 well plate and 
allowed to stand for 5 min at room temperature. Then 15 l AlCl3 (wako, Japan, 10% 
w/v in ddH2O) were added and incubated for an extra 5 min at room temperature. 
Finally, 50 l NaOH (1 M) were added, immediately the mixture was diluted by the 
addition of 27.5 l of ddH2O. The absorbance was recorded at 510 nm using a 
multidetection microplate reader (Powerscan HT, Dainippon Pharmaceutical, NJ, USA). 
The results were expressed as quercetin equivalents (QE) in mg/g of olive leaves extract 
dry weight (mg QE g
–1
). All extracts were analyzed in triplicate. 
 
4. 2. 5 DPPH radical scavenging assay 
The antioxidant effect of olive leaves was determined using a 
1,2-diphenyl-2-picrylhydrazy (DPPH) radical scavenging assay micro-method. The 
reaction mixture (190 l) containing 0.2 mM DPPH dissolved in EtOH, 50 mM 
2-(N-morpholino) ethanesulfonic acid (MES) buffer (pH 6.1), and 10 l of diluted 
extract or a standard solution of trolox (Sigma-Aldrich, St. Louis, MO, USA) in EtOH 
were added to each well of 96-well microplate and incubated for 10 min at room 
temperature in darkness. The absorbance was recorded at 520 nm using a multidetection 
microplate reader (Powerscan HT, Dainippon Pharmaceutical, NJ, USA). The results 
were expressed as trolox equivalent antioxidant capacity (TEAC) in mM/g of olive 
leaves extract dry weight (mM TEAC g
–1
). All extracts were analyzed in triplicate. 
 
4. 2. 6 Statistical analyses 
Results are expressed as means ± SD. Differences at P < 0.05 were considered 
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s   is i  lly sig ifi    . S   is i  l    lysis w s p  fo m d usi g S ud   ’s  -test on the 
data of functional activity assay. Data of individual phenols, flavonoids and anti-oxidant 
activity were analyzed using one way ANOVA followed by Tukey post hoc test to 
assess for significant differences between different Tunisian olive leaves. Further, 
principal component analysis (PCA) was used as multivariate statistical tool in order to 
interpret the correlations between physico-chemical profiles of olive leaves cultivar and 
their geographical origin, using StatGraphics 5.0. 
 
 
 
Table. 4. 1  
Description of different olive leaves sample collected in Tunisia: sampling point 
location, variety, fruit harvesting period, and abbreviation of each sample. 
Location Latitude N Longitude E Variety
a
 Harvesting period Abbreviation 
Borj Ettoumi 36.76764 9.691806 Chetoui  (n=5) Nov – Jan BC 
Borj Ettoumi 36.75344 9.699806 Meski   (n=5) Nov – Jan BM 
Metline 37.24331 10.07 Chetoui  (n=5) Dec – Jan MC 
Oum heni 37.08364 9.82725 Chetoui  (n=5) Nov – Feb OC 
Oum heni 37.08364 9.82725 Chemlali (n=3) Nov – Feb OCL 
Oum heni 37.08364 9.82725 Meski   (n=5) Nov – Feb OM 
Sidi Hasseine 36.75122 10.12128 Chetoui  (n=5) Jan – Feb SC 
Sidi Hasseine 36.75122 10.12128 Sahli    (n=5) Jan – Feb SS 
Takelsa 36.79881 10.63333 Chetoui  (n=5) Nov – Jan TC 
a) The number of samples was that of olive trees from which were collected leaves.  
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Fig. 4. 1 The location of sampling point in Tunisia. (A)Outline map of Tunisia, (B) map 
of northern part in Tunisia.  
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4. 3 Results 
 
4. 3. 1 Quantitative analysis of apigetrin and apigenin in olive leaves  
HPLC profiles of phenolic compounds present in olive leaves were shown in 
Fig. 4. 2C. The retention times of the apigetrin and apigenin in olive leaves extract were 
13.89 min and18.12 min, respectively (Fig. 4. 2D). Fig. 4. 3 showed the overlay 
chromatogram of representative for each representative samples. As shown in Table. 4. 
2, apigetrin content in olive leaves ranged from 2.52  0.35 to 4.60  1.35 g/g DW. 
The order of mean apigetrin content was Meski/Oum heni > Chetoui/Takelsa > 
Chetoui/Sidi Hasseine, Sahli/Sidi Hasseine > Chemlali/Oum heni > Chetoui/Borj 
Ettoumi > Meski/Borj Ettoumi > Chetoui/Oum heni > Chetoui/Metline. Apigenin 
content in olive leaves ranged from 0.45  0.03 to 0.97  0.15 g/g DW. The order of 
mean apigenin content was Sahli/Sidi Hasseine > Chetoui/Takelsa > Meski/Oum heni > 
Chetoui/Metline > Chemlali/Oum heni > Meski/Borj Ettoumi > Chetoui/Sidi Hasseine > 
Chetoui/Borj Ettoumi > Chetoui/Oum heni. Analysis of variance (ANOVA) showed 
difference between samples, further Tukey post hoc test showed the difference between 
high and low apigetrin content. Moreover the results revealed that apigenin was present 
in olive leaves mostly as glucoside form in contrast the aglycon form was present as 
trace.  
 
4. 3. 2 Total flavonoids and total phenolics content in olive leaves, and their 
antioxidant capacity 
Total flavonoids and total phenolic contents in olive leaves dtermined by 
calorimetric assay. This analysis of micro methods developed in our laboratory makes it 
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possible to improve the high throughput screening. As shown in Table. 4. 2, total 
flavonoids content in olive leaves ranged from 165.73  57.16 to 447.79  152.06 mg 
QE/g DW. The order of mean total flavonoids was Chetoui/Takelsa > Chetoui/Sidi 
Hasseine > Chetoui/Borj Ettoumi > Sahli/Sidi Hasseine > Meski/Borj Ettoumi > 
Chemlali/Oum heni > Chetoui/Oum heni > Chetoui/Metline > Meski/Oum heni. Total 
phenolics content in olive leaves ranged from 12.44  2.19 to 20.78  4.05 mg GAE/g 
DW. The order of mean total phenolics was Chemlali/Oum heni > Chetoui/Borj Ettoumi 
> Meski/Oum heni > Chetoui/Oum heni > Chetoui/Metline > Sahli/Sidi Hasseine > 
Chetoui/Taklsa > Chetoui/Sidi Hasseine > Meski/Borj Ettoumi. DPPH radical is well 
known as a stable organic free radical which has been used for estimation of the 
antioxidant capacity. DPPH radical is changed to nonradical to react antioxidants. We 
determined the antioxidant capacity of 9 samples (Table. 4. 2). The antioxidant capacity 
in olive leaves ranged from 479.64  66.38 to 698.26  24.05 mM TEAC/g DW. The 
order of mean antioxidant capacity was Chemlali/Oum heni > Chetoui/Borj Ettoumi > 
Sahli/Sidi Hasseine > Chetoui/Oum heni > Chetoui/Takelsa > Chetoui/Metline > 
Meski/Oum heni > Meski/Borj Ettoumi > Chetoui/Sidi Hasseine. 
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(A)                                   (B) 
       
 
(C) 
 
 
 
Fig. 4. 2 Chemical structure of apigetrin (A) and apigenin (B). HPLC chromatogram at 
280 nm of (1) olive leaves extract, (2) apigenin standard and (3) apigetrin (C). Retention 
time of apigetrin and apigenin in olive leaves extract were 13.89 min and 18.12 min 
respectively. 
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Fig. 4. 3 R p  s     i   HPLC  h om  og  m of    h    i  y’s oli   l    s  x     , 
comparison at 100 mg of fresh weight leaves equivalent;  (1)MC, (2)OC, (3)OM, 
(4)OCl, (5)BC, (6)BM, (7)SS, (8)SC, (9)TC.  
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 Table. 4. 2 
Mean Composition and Standard Deviation of different chemical descriptor of olive 
leaves extracts: Apigetrin (g/g DW), Apigenin (g/g DW), Total flavonoids (mg QE 
g
-1
 DW), Total phenolics (mg GAE g
-1
 DW), and Antioxidant activity (mM TEAC g
-1
 
DW).  
Sample Apigetrin Apigenin Total flavonoids Total phenolics 
Antioxidant 
activity 
BC 3.32  0.50
ab
 0.46  0.18
 a
 391.07  109.62
 acd
 16.58  2.07
 ab
 650.21  28.39 
ab
 
BM 3.14  0.44
 ab
 0.52  0.16
 a
 267.91  148.74
 abd
 12.44  2.19
 a
 490.84  141.78
 ac
 
MC 2.52  0.35
 a
 0.60  0.37
 ab
 198.94  45.67
 ab
 15.89  0.96
 a
 549.20  54.69
 abc
 
OC 2.68  0.12
 a
 0.45  0.03
 a
 236.66  78.90
 abd
 15.91  1.54
 a
 575.81  73.07
 abc
 
OCL 3.60  0.20
 ab
 0.59  0.02
 ab
 263.32  73.19
 abcd
 20.78  4.05
 b
 698.26  24.05
 b
 
OM 4.60  1.35
 b
 0.62  0.17
 ab
 165.73  57.16
 b
 16.26  2.75
 ab
 504.57  75.41
 ac
 
SC 4.52  0.49
 b
 0.50  0.10
 a
 459.79  113.70
 cd
 14.38  0.64
 a
 479.64  66.38
 c
 
SS 4.52  0.46
 b
 0.97  0.15
 b
 362.85  91.71
 abcd
 15.56  1.52
 a
 617.35  72.14
 abc
 
TC 4.58  1.13
 b
 0.65  0.37
 ab
 447.79  152.06
 d
 15.15  1.69
 a
 563.13  89.76
 abc
 
Values are expressed as means SD (n=5) for HPLC analysis, with exception for OCL 
(n=3), and also (N=5) for total flavonoids, total phenolics, and antioxidant activity, with 
exception for OCL (n=3). Means with different letters in the same column were 
significantly different at the level p<0.05 (One way ANOVA followed by Tukey post 
hoc test).       
 
 
4. 3. 4 PCA analysis 
PCA was applied to the dataset of apigetrin, apigenin, total falvonoids, total 
phenolics and antioxidant capacity (TEAC) of four olive cultivar leave sample collected 
from five sites in Tunisia during November 2011 (Fig. 4. 4). PCA accounted for 72.11% 
cumulative variance with 37.83% for PC1 and 34.28 %for PC2. PCA plot (Fig. 4. 4) 
generated 4 distinctive groups :(i) Chemlali cultivar grown in Oum Heni area (OCL) 
which is characterized by high phenolic content and high anti-oxidant capacity, (ii) 
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Meski cultivars grown in Oum Heni and Borj Toumi (OM and BM), (iii) Chetoui 
cultivar grown in Borj Toumi, Oum Heni, and Metline (BC, OC, and MC), and (iv) the 
last groups is composed by three sample which are Sahli and Chetoui cultivar grown in 
Sidi Hassine and Takelsa (SS, TC, SC).  
PC1 was highly correlated with total phenolic content and antioxidant capacity 
TEAC while PC2 was highly correlated with apigenin and apigetrin content. Moreover, 
Fig. 4.5 shows that there is high correlation between total phenolics and TEAC (p<0.05) 
on the one hand apigetrin and total flavonoids (p<0.05). This results is concordant with 
previous findings and demonstrates that phenolics are the main compounds to contribute 
to total anti-oxidant capacity, and apigenin aglycone or glucoside highly contribute to 
total flavonoids content. 
 
 
Fig. 4. 4 Principal Component Analysis (PCA) for chemiometric analysis in Tunisian 
olive leaves extracts. Abbreviations: Ap_7G: Apigetrin, Ap: Apigenin, Tot_PP: total 
phenolics, Tot_F: total flavonoids, TEAC: Trolox equivalent antioxidant capacity.  
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(A) 
 
(B) 
 
Fig. 4. 4 Correlation Analysis for chemiometric analysis in Tunisian olive leaves 
extracts (n=43). Relationship between total phenol and anti-oxidant activity is shown 
(A) and apigetrin and total flavonoid is shown (B).  
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4. 4 Discussion 
 
Olive phytochemicals are highly available in olive leaves and could be 
extracted and purified with low cost in order to be used as functional food supplement 
or food additives. Herein, the author s      d 4 Tu isi   oli      i  i s’ l    s  x     : 
Chetoui, Chemlali, Meski, and Sahli grown in 5 sites in the northern part of Tunisia, for 
their total polyphenol, total flavonoid, and apigenin content and their anti-oxidant 
capacity using analytical micro-methods. Results demonstrated a significant difference 
between cultivars and growing sites. Although the study lacked some limitations (did 
not take in consideration climatic stage effect, wider regional disparities, and farming 
techniques), the PCA revealed that the studied parameters could discriminate between 
olive cultivars and growing sites, generating 4 different sub-groups with high content of 
apigenin in Chetoui cultivars and high polyphenol content in Chemlali cultivar. Meski 
cultivar showed low content of apigenin and polyphenol compared to other cultivars as 
revealed by PCA sub-group analysis. Meski cultivars are situated in the lower quadrant 
of PCA biplot and negatively correlated with flavonoids, phenolics, apigenin and 
Anti-oxidant activity. Even there are thousands of varieties of the Olea europaea olive 
tree, there are two major varieties which are as follows; Chetoui in the north, Chemlali 
in the middle and south of Tunisia. Various other types of olive may be found such as 
Meski which is in north and newly irrigated area. According to the Seeds and Plant 
     i  R sou   s    m of FAO’s Pl    P odu  io    d P o    io  Di isio  (A P), 
Chetoui has the middle content of oil used for oil, Chemlali has the high content of oil 
used for oil, and Meski has the low content of oil used for table. This finding is 
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concordant with the common use of the variety in Tunisia, since it is frequently used for 
table olive preparation and the other varieties are used for olive oil production.  
Meanwhile the biosynthesis of apigenin starts from three molecules of 
malonyl-CoA and one of 4-coumaroyl- CoA (Petrussa et al., 2013). Indeed, flavonoids 
including apigenin are often present in the epidermal cell layers of leaves and in tissues 
that are susceptible to UV light, than pollen and the apical meristem (Winkel-Shirley, 
2002). Hahlbrock et al. (1971) showed that increase of apigenin was induced by light 
irradiation via activation of synthesized enzymes in cell suspension cultures of parsley, 
provided the evidence that UV light induces the synthesis of flavonoids. Several studies 
have revealed the effect of temperature and also water deficit on the concentration of 
flavonoids (Ojeda et al., 2002, Yamane et al., 2006). There is also interesting evidence 
that flavonoids accumulates for aluminum-resistant in roots of maize (Kidd et al., 2001). 
The accumulation of flavonoids is still controversial due to many aspects. On the other 
hand Meski cultivar, which is characterized by bigger size of fruits, showed low content 
of apigenin and polyphenol compared to other cultivars as revealed by PCA sub-group 
analysis. Utilization of malonyl-CoA and 4-coumaroyl- CoA, which are starting 
molecules of apigenin biosynthesis and also primary metabolite, possibly to be 
considered as antagonistic to metabolism in the case of growing. The current study 
focused on olives grown in the northern area of Tunisia, but further studies using 
samples grown in all Tunisian territory and why not in mediterranean region will be 
required for the evaluation of climate and environmental effect on chemical descriptors 
in olive leaves.  
The content of apigetrin was highly correlated with apigenin content and total 
phenolic content with ant-oxidant activity. The anti-oxidant compound was reported as 
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the potential differentiation inducer in HL-60 cells (Sokoloski et al., 1997). The results 
in this chapter did not demonstrate a correlation between apigenin content and 
anti-oxidant activity, but the possibility of apigenin as potent strong differentiation 
inducer in human leukemia cells. The current study highlighted apigenin content as a 
selecting parameter for olive leave extract (all the extracts available in the market are 
based on oleuropein and hydroxytyrosol percentages). Several studies have reported that 
apigenin glucoside is only available in olive leaves and not in olive oils (Brenes et al., 
1999; Christophoridou and Daris, 2009; Fu et al., 2009; García-González, et al., 2010; 
Molina-Alcaide and Yáñez-Ruiz, 2008; Murkovic et al., 2004). In contrast the aglycon 
form is released in olive oil because the hydrolysis reaction occurs during the 
mechanical process of olive oil production. The current results indicate that olive leaves 
apigenin is mostly present as glucoside not aglycon form (Table. 4. 1) which is 
concordant with previous reports (Abaza et al., 2007). Apigetrin is more useful 
compared to apigenin aglycon in the point of stability, solubility, palatability and 
bioavailability (Patel et al., 2007). 
There is traditional and widespread use of olive leaves and olive-leaf tea in 
Mediterranean region. In Tunisia, despite its small area, there is 70 million olive trees 
covering 1,700,000 ha and there are dozens of identified cultivars in the country. 
However, Chetoui in the northern part, and Chemlali in the middle and the southern part 
of the country are the main cultivar. Other cultivars like Meski, Sahli, Chemchali, 
Oueslati, baldi, Zarrazi, Zalmati, Gerboui, Sayali, etc.... are frequent in some part of the 
country (Trigui et al., 2002). Moreover, some Spanish and Greek cultivar like 
Arbequina, Arbosana, and Koroneiki were recently introduced to the country. World 
widely, there is an increasing interest in olive products phenolics, and this is due to their 
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high biological and pharamacological properties. In this respect, apigenin-rich olive 
leaves extract would be a promising issue for industrial valorization of olive leaves in 
Tunisia and in Mediterranean countries.  
In this chapter, the author showed that olive leaves have proved their capacity 
for storage of phenolic compounds such as apigenin, as glucoside derivatives. This 
study supports the potential of leaves source for isolation of the target compounds on an 
industrial scale, and highlighted Tunisian olive lea  s’ apigenin content and 
bioactivities and reported that Chetoui would be the variety with the highest 
concentration. Moreover, we demonstrated that analytical micro-methods which are cost 
and time effective could be considered as important tool for chemical and biological 
screenings. Finally, this study although it has some limitations it can be helpful tool for 
industrial, academic researchers, and decision makers, and may contribute to 
elaboration of large scale and more comprehensive screening studies 
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Chapter 5 
 
 
General conclusion 
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Cancer is one of the major public health burdens in many countries. Global 
cancer incidence is increasing dramatically; In fact 12.7 million cancer cases and 7.6 
million cancer deaths are estimated to have occurred in 2008 (Jemal et al., 2011). Blood 
cancers are among the most severe and virulent forms of cancer. In 2010 leukemia 
caused the death of 281,500 persons (Lozano et al., 2012) with a lower incidence in 
Mediterranean countries (Jemal et al., 2011). Physical exercise and healthy diet like the 
Mediterranean one are among WHO recommendation to reduce the burden and 
incidence of cancer. Cumulating evidence demonstrated that polyphenol-rich diet 
reduced the incidence and the prevalence of malignancies (Fresco et al., 2010). 
Epidemiological studies reported a lower incidence of cancer among Mediterranean 
people and this could be related to the diet rich in fruits, vegetables and olive oil 
(Filomeno ei al., 2014; Castelló et al., 2014). Olive oil minor compounds were reported 
in our previous studies and by others to be efficient against malignancies (Abaza et al., 
2007; Tsolmon et al., 2011). Cancer prevention aims at blockage or reversal of the 
initiation phase of carcinogenesis or arrests it at progression stage. In this context, plant 
derived naturally occurring constituents may be largely involved since increased 
consumption of fruits and vegetables correlates with lower incidence of cancer (Visioli 
et al., 2000). Here the author tried to investigate yet another approach of cancer 
prevention such as cancer cell differentiation using a common non-mutagenic flavonoid 
apigetrin. 
In chapter 2, the author showed that apigetrin inhibited HL-60 cell growth, 
dose- and time-dependently, but did not cause apoptosis. The distribution of cells at 
different stages in the cell cycle indicated an accumulation of treated cells in G2/M 
phase. Moreover, apigetrin induced granulocytic differentiation of HL-60 cells. The 
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common view that the initiation of cell differentiation is most likely to occur at the 
G0/G1 phase was not followed in the case of apigetrin. Therefore it might be interesting 
to investigate the differentiation pathway with apigetrin treatment and explore novel 
players in the complex process of cellular signaling.  
To consider these findings in a clinical application, in vivo safety and efficacy 
studies of apigenin and apigetrin should be reported. Apigenin’ pharmacokinetic study 
was reported by Gradolatto et al. (2005) showed that a single oral administration of 
radio-labeled apigenin in rats appeared in blood plasma after 24 h and resulted in 24.8% 
in the rest of the body within 10 days. It has been also reported that apigenin is very 
effective against several cancer animal models except leukemia. Orally administered 
apig  i   (20   d 50 μg/mous /d y, 6 d ys/w  k fo  20 w  ks) resulted in a significant 
decrease in tumor volumes of prostate in transgenic adenocarcinoma mice model  
indicating that apigenin inhibits prostate cancer progression (Shukla et al., 2014). Same 
doses of apigenin following 8 weeks treatment induced apoptosis in prostate tumor 
xenografts in nude mice (Shukla and Gupta, 2006). Another in vivo study of apigenin 
(40 mg/kg apigenin for 7 days as intraperitoneally injection), improved glucose 
tolerance in miR103 transgenic mice (Ohno et al., 2013). Moreover, oral administration 
of apigenin at 5, 10, and 20 mg/kg/day decreased furan-induced toxicity in liver and 
kidney on mice (Wang et al., 2014). On the other hand, safety of apigenin was evaluated 
following acute exposure though intraperitoneal injection of apigenin at doses of 25, 50, 
100 and 200 mg/kg in Swiss mice. The liver function makers, serum ALT, AST and ALP, 
in 25 or 50 mg/kg apigenin doses indicated that it has no toxic effect at these doses. In 
contrast these markers significantly increased in 100 and 200 mg/kg apigenin doses, 
indicating a severe hepatotoxicity (Singh et al., 2012). Taken together, previously 
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reported studies demonstrated that apigenin is expected to be effective against cancer at 
low dose without any side effects. Further studies are required to evaluate apigein 
benefit on leukemia in small animal models. 
In chapter 3, the author showed that ten proteins that might play essential role 
in granulocytic differentiation which is previously-unreported as proteins related to 
differentiation, and a possible role for Chk1 and Chk2 in the granulocytic differentiation 
on HL-60 cells. To summarize identified 10 proteins by proteomics, apigenin, which is 
hydrolyzed by glucosidase from apigetrin, inactivates hnRNP A2 by directly binding, 
and activates phosphorylate Chk1 and Chk2, which might lead to signal transduction 
toward G2/M cell cycle arrest through 14-3-3 proteins interacted with PCNA. PCNA 
coordinates multiple functions to bind many proteins especially EF-1 in protein 
synthesis according to differentiation. Besides RbAp48 is related transcriptional 
regulation implicated in granulocytic differentiation. Plastin-2, annexin A5 and 
coronin-1A are involved in granulocytes feature and support the induction of 
differentiation by apigetrin.  
hnRNP A2, apigenin target protein has been reported its higher expression in 
several human cancers, including breast (Zhou et al., 2001), and hnRNPA2 expression 
is recognized as a marker of glioblastoma and lung cancer (Golan-Gerstl et al., 2011, 
Sueoka et al., 2005, Wu et al., 2003). This study does not only support the potential of 
Apigenin also for leukemia but also suggest hnRNP A2 as a marker of leukemia. Stem 
cell study, that hnRNP A2 regulates self-renewal and pluripotency in hESC, supports 
hnRNP A2 is key regulator of cell differentiation. Further study requires to evaluate the 
relationship between hnRNP A2 and leukemia differentiaion mechanism. Apigenin 
reported to have high binding affinity compared with another flavonoid (Arango et al, 
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2013), that lead to strong potential of apigenin for anti-carcinogenesis compared with 
another flavonoids.  
In chapter 4, the author showed that olive leaves have proved their capacity for 
storage of phenolic compounds such as apigenin, as glucoside derivatives. 
In fact, pruning generates 25 kg of leaves/ tree (Molina-Alcaide and 
Yáñez-Ruiz, 2008). In Tunisia, there is around 70 million trees which means potentially, 
this country can produce 1.750.000 ton of olive leaves. However, a lot of efforts are 
required in order to standardize olive leaves extracts, because several conditions: such 
as variety, growing area, season and plant part may significantly influence its chemical 
composition (Luján et al., 2009). However Damak et al. (2008) and Luján et al. (2009) 
reported the content of phenols in olive oil analyzed by LC/MS decreased over the 
season. As maturing progress olive fruits become darken and the oil content increases, 
at the same time the photosynthetic activity decreases and the concentration of phenols 
also decrease progressively. Olive is an evergreen tree, therefore leaves does not modify 
their chemical composition over a season as far as they are not affected by external 
factors compared with their oils. Taken together, results in this chapter also indicate the 
key role of leaves as stable source of phenol apigenin from olive trees. 
This study supports the potential of leaves source for isolation of the target 
compounds on an industrial scale. Although this sector is strategic and promising for 
Tunisian economy, there are several challenges: (i) irregularity of yield due to 
traditional farming systems, (ii) the harvesting and pressing methods need to be 
improved (iii) quasi-absence of Tunisian olive oil brand in the international market. In 
this respect, olive tree farming and olive oil production by-products should be highly 
valorized in order to diversify olive sector products, contribute to upgrading the olive 
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oil sector. This study will address a specific attention to Tunisian olive leaves 
valorization with a focus on apigenin health benefits and supports the potential of leaves 
source for isolation of the target compounds on an industrial scale. 
In conclusion, the author has demonstrated that plant flavone apigetrin not only 
induces apoptosis of different cancer cells but also has a potential to induce cell 
differentiation. This study will contribute not only in the findings of the differentiation 
inducing effect of apigetrin but also the development of apigetrin as a potential inducer 
of leukemia cell differentiation and a functional food by molecular mechanism analysis. 
Moreover the author has demonstrated that olive leaves prospect as low cost 
apigenin-rich byproducts as a functional material for the industrial application. The 
author expect that this findings may contribute to understand different approaches of 
chemopreventive properties of natural compounds against cancer disease and the usage 
of olive leaves as a stable source. 
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Summary 
 
 
Several epidemiologic studies have reported associations between high 
consumption of fruits and vegetables and reduced risk of cancer. However these 
findings are inconsistent and their mechanism of action on cellular and tissue levels are 
limited. The current study was conducted to investigate cancer prevention using cancer 
cell differentiation strategy. Herein, the author reports the effect of a common 
non-mutagenic flavonoid apigetrin on human acute promyelocytic leukemia using 
HL-60 cell model. 
Apigenin is abundantly present in common fruits and vegetables, such as 
parsley, onions as well as in olive products (oil, fruits and leaves). Several studies 
reported that apigenin inhibits cancer cell growth via cell cycle arrest and apoptosis. 
This strategy may be clinically limited because of its cytotoxicity. Recently there is an 
increase in the usage of another mild approach such as cancer cell differentiation. 
However, few research studies have been reported about apigenin activity. 
 In this study, apigetrin inhibits cell growth dose- and time-dependently in 
HL-60 cells without cytotoxic effects. The cell cycle distribution of apigetrin 
treated-cells showed G2/M phase arrest. Moreover, apigetrin treatment induced HL-60 
cell morphological changes (big cell size and cells with lobed nucleus). These 
observations were confirmed by the expression of cell surface differentiation markers 
CD11b and CD14, and NBT reduction assay, revealing HL-60 cell granulocytic 
differentiation. The common view that the initiation of cell differentiation is most likely 
to occur at the G0/G1 phase arrest, suggests the potential role of apigetrin as a novel 
player of cellular signal transduction. To elucidate this molecular mechanism, the author 
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performed advanced molecular biology approach based on proteomics. 
 Proteomics results showed significant expression of ten proteins which were 
relevant to granulocytes function and signaling. Based on these results, the author found 
that apigetrin induced-signaling was regulated at post-translational level. The author 
demonstrated that apigetrin activity was triggered by Chk1 and Chk2 phosphorylation. 
This finding is in concordance with previous report about the key role of Chk1 and 
Chk2 in the granulocytic differentiation in HL-60 cells. 
 Since this study was designed for apigetrin as a functional food product. The 
author was prospecting low cost apigenin-rich byproducts. This study demonstrated that 
olive leaves could be the target. HPLC analysis of several Tunisian olive cultivars 
growing in different area demonstrated that olive leaves present high amounts of 
apigenin as glucoside form. This study supports the potential valorization of olive leaves 
at industrial scale. 
 In conclusion, this study will contribute not only in the findings of the 
differentiation inducing effect of apigetrin but also the development of apigetrin as a 
potential inducer of leukemia cell differentiation and a functional food by molecular 
mechanism analysis. The author expects that current findings may contribute to 
understand different approaches of chemopreventive properties of natural compounds 
against cancer disease and the usage of olive leaves as a stable source. 
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